Home
Biotechnology Value Fund reported a 5.3% stake in Avalo Therapeutics AVTX · 2,801,545 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5.3%
- Last report
- 9.99% · filed 26/05/15
- Shares held
- 2,801,545 sh
- Class
- Common Stock, $0.001 par value per share
- Holder
- Biotechnology Value Fund
- Event date
- 26/06/30
- Filed
- 26/08/14
5.3% stake · −4.7pp from the last report
- Stake
- 5.3%
- Last report
- 9.99%
- Since last report
- −4.7pp
Avalo Therapeutics trades, last 26 weeks
What else happened in Avalo Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Biotechnology Value Fund's other 5% stake reports
- Biotechnology Value Fund
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
6.1% stake
4,215,886 sh
6.1% stake
Filed 09/21
- Biotechnology Value Fund
5% stakeAlector
5% stakeAlector
ALEC
8.4% stake
9,374,267 sh
8.4% stake
Filed 09/18
- Biotechnology Value Fund
5% stakePalvella Therapeutics
5% stakePalvella Therapeutics
PVLA
4.7% stake
672,789 sh
4.7% stake
Filed 08/14
- Biotechnology Value Fund
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
8% stake
3,235,778 sh
8% stake
Filed 08/14
- Biotechnology Value Fund
5% stakeNektar Therapeutics
5% stakeNektar Therapeutics
NKTR
7.1% stake
2,391,075 sh
7.1% stake
Filed 08/14
